Crossref
EE382 PRICE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION
Value in Health · 2026-06 · 29 (6) · S135-S136
DOI: 10.1016/j.jval.2026.03.676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Anna Pelc und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pelc, A., Rahimian, M., Bakare, A. S., Brown, L. M., Fleming, M. L., Shukla, V., Rodriguez-monguio, R., & Seoane-Vazquez, E. (2026). EE382 PRICE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION. Value in Health, 29(6), S135-S136. https://doi.org/10.1016/j.jval.2026.03.676
Vancouver
Pelc A, Rahimian M, Bakare AS, Brown LM, Fleming ML, Shukla V, et al. EE382 PRICE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION. Value in Health. 2026;29(6):S135-S136. doi:10.1016/j.jval.2026.03.676
BibTeX
@article{Pelc2026,
author = {Pelc, Anna and Rahimian, Mana and Bakare, Adeola S. and Brown, Lawrence M. and Fleming, Marc L. and Shukla, Vaishali and Rodriguez-monguio, Rosa and Seoane-Vazquez, Enrique},
title = {EE382 PRICE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S135--S136},
doi = {10.1016/j.jval.2026.03.676}
}
EUVIMED